Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

0.9586
-0.1714-15.17%
Volume:11.49M
Turnover:10.69M
Market Cap:209.65M
PE:-0.72
High:1.10
Open:1.09
Low:0.8621
Close:1.13
Loading ...
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 15, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 04, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2020

Major Issues Report

8-K - Current report
Oct 26, 2020

Major Issues Report

8-K/A [Amend] - Current report
Aug 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2020

Major Issues Report

8-K - Current report
Jul 10, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 11, 2020

Major Issues Report

8-K - Current report
Jun 04, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Major Issues Report

8-K - Current report
May 06, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 27, 2020

Major Issues Report

Current report, item 8.01
Feb 27, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]